ELV NYSE
Elevance Health Inc.
1W: -2.0%
1M: -2.4%
3M: +8.2%
YTD: +8.9%
1Y: +34.8%
3Y: -15.7%
5Y: +5.2%
$385.73
+7.37 (+1.95%)
Weekly Expected Move ±7.3%
$323
$350
$378
$405
$432
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$2.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$83.7B
52W Range273.71-436.24
Volume1,233,465
Avg Volume1,701,542
Beta0.68
Dividend$6.86
Analyst Ratings
Company Info
CEOGail Koziara Boudreaux
Employees97,100
SectorHealthcare
IndustryMedical - Healthcare Plans
IPO Date2001-10-30
Websiteelevancehealth.com
220 Virginia Avenue
Indianapolis, IN 46204
US
Indianapolis, IN 46204
US
800 331 1476
About Elevance Health Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Latest News
Centene Q2 Earnings Beat Estimates on Increasing Premiums
UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures
Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook
Can Humana Beat Q2 Earnings Estimates on Growing Premiums?
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BOUDREAUX GAIL | P-Purchase | 680 | $366.41 | 2026-07-17 |
| BOUDREAUX GAIL | P-Purchase | 2,045 | $368.25 | 2026-07-17 |
| PERU RAMIRO G | P-Purchase | 1,000 | $366.05 | 2026-07-17 |
| Penczek Ronald W | S-Sale | 369 | $403.16 | 2026-06-12 |
| Dixon Robert L JR | S-Sale | 151 | $401.77 | 2026-06-11 |